Hinoon (Lab) (HINOON) Stock Price and Company Financials
Rs. 948.13
Rs. 3.47 (0.37%)
Last updated: 2026-09-28
Annual Financials (Latest Year: 2025)
SalesRs. 25,789,242,000
Total revenue generated from core business operations during the year.
Profit After TaxRs. 4,119,313,000
Net earnings after all expenses, interest, and taxes – the "bottom line".
Earnings Per Share (EPS)Rs. 77.75
Profit allocated to each share – higher EPS means better profitability per share.
Gross Profit Margin54.78%
Percentage of revenue left after deducting cost of goods sold – shows production efficiency.
Net Profit Margin15.97%
What percentage of revenue becomes actual profit after all expenses – a key profitability measure.
EPS Growth26.61%
Year‑over‑year increase in earnings per share – indicates growing profitability.
Business Description:
Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products. The registered office of the Company is situated at 17.5 km, Multan Road, Lahore.
Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products. The registered office of the Company is situated at 17.5 km, Multan Road, Lahore.
*Annual figures from latest financial statement
| Open | Close | Low | High | Volume |
|---|---|---|---|---|
| 951.60 | 948.13 | 942.01 | 957.01 | 1,800 |